Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$314.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jun 15 | CHRO | Channel Therapeutics Corp | SSELL◷ | 59 | $27.94 | $1.6K | <0.1% | Open the original filing on SEC.gov |
| Jun 15 | CHRO | Channel Therapeutics Corp | SSELL◷ | 224 | $27.12 | $6.1K | -0.3% | Open the original filing on SEC.gov |
| May 14 | CHRO | Channel Therapeutics Corp | FTAX◷ | 144 | $27.01 | $3.9K | -0.2% | Open the original filing on SEC.gov |
| Apr 2 | CHRO | Channel Therapeutics Corp | SSELL◷ | 265 | $21.36 | $5.7K | -0.3% | Open the original filing on SEC.gov |
| Apr 2 | CHRO | Channel Therapeutics Corp | SSELL◷ | 293 | $20.51 | $6K | -0.4% | Open the original filing on SEC.gov |
| Nov 25, 2025 | CHRO | Channel Therapeutics Corp | SSELL | 2,000 | $28.01 | $56K | -6.3% | Open the original filing on SEC.gov |
| Nov 25, 2025 | CHRO | Channel Therapeutics Corp | SSELL | 1 | $28.50 | $29 | 0.0% | Open the original filing on SEC.gov |
| Nov 25, 2025 | CHRO | Channel Therapeutics Corp | SSELL | 2,000 | $28.14 | $56.3K | -5.9% | Open the original filing on SEC.gov |
| Nov 25, 2025 | CHRO | Channel Therapeutics Corp | SSELL | 5,999 | $28.00 | $168K | -15.0% | Open the original filing on SEC.gov |
| Jul 2, 2025 | CHRO | Channel Therapeutics Corp | AGRANT◆ | 58,230 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | CHRO | Channel Therapeutics Corp | AGRANT◆ | 19,108 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | CHRO | Channel Therapeutics Corp | AGRANT↺ | 19,108 | — | — | +30.1% | Open the original filing on SEC.gov |
| Jul 1, 2025 | CHRO | Channel Therapeutics Corp | CCONV◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | CHRO | Channel Therapeutics Corp | CCONV◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | CHRO | Channel Therapeutics Corp | PDBUY◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | CHRO | Channel Therapeutics Corp | PDBUY◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | CHRO | Channel Therapeutics Corp | CCONV | 40,000 | $10.00 | $400K | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | CHRO | Channel Therapeutics Corp | CCONV | 40,000 | $10.00 | $400K | — | Open the original filing on SEC.gov |
| Nov 13, 2024 | CHRO | Channel Therapeutics Corp | AGRANT↺ | 2,454 | — | — | +4.0% | Open the original filing on SEC.gov |
| Jun 14, 2024 | CHRO | Channel Therapeutics Corp | AGRANT↺ | 6,450 | — | — | +11.8% | Open the original filing on SEC.gov |